Management of hereditary angioedema: 2010 Canadian approach.
Allergy Asthma Clin Immunol
; 6(1): 20, 2010 Jul 28.
Article
em En
| MEDLINE
| ID: mdl-20667123
ABSTRACT
C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http//www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Allergy Asthma Clin Immunol
Ano de publicação:
2010
Tipo de documento:
Article
País de afiliação:
Canadá